Evaluation of multilayer coated magnetic nanoparticles as biocompatible curcumin delivery platforms for breast cancer treatment. Issue 107 (16th October 2015)

• Record Type: Journal Article
• Authors: Akrami, Mohammad; Khoobi, Mehdi; Khalilvand-Sedagheh, Masoud; Haririan, Ismaeil; Bahador, Abbas; Faramarzi, Mohammad Ali; Rezaei, Shahla; Javar, Hamid Akbari; Salehi, Fahimeh; Ardestani, Sussan Kabudanian; Shafiee, Abbas
• Is Part Of: RSC advances. Volume 5:Issue 107(2015)
• Page Start: 88096
• Page End: 88107
• Publication Date: 2015-10-16
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c5ra13838h
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : A novel biocompatible multi-layer iron oxide magnetic nanoparticles with sustained sensitive release profile, and improved cellular uptake. Abstract : Biocompatible multi-layer iron oxide magnetic nanoparticles (MNPs) for drug delivery applications with increased loading capacity, sustained sensitive release profile, and high inherent magnetic properties as well as improved cellular uptake were prepared. In this approach, Fe3 O4 MNPs were obtained by a co-precipitation method and functionalized using hydroxyapatite (HAP) and/or polyethyleneimine (PEI). They were then modified with β-cyclodextrin (CD) to increase their loading capacity. These MNPs allowed suitable encapsulation of hydrophobic curcumin (CUR) in the CD shell and CUR adsorption into the polymeric layers. The dissolution profile of CUR showed pH sensitive release of CUR. The protein corona pattern of the MNPs by electrophoresis showed lower protein adsorption for CD modified MNPs than for other MNPs. No significant toxicity was observed for the target MNPs, whereas the CUR loaded MNPs inhibited MCF-7 breast cancer cells more efficiently than free CUR. Moreover, the negligible hemolytic activity of the target MNPs showed their excellent haemocompatibility for cancer treatment. The preferential uptake of the drug by MCF-7 cells was observed for CUR loaded MNPs in comparison with free CUR using flow cytometric analysis. As a result, the designed and prepared MNPs can be considered to be a promising CUR delivery platform.